AstraZeneca is considering moving its stock market listing from London, where it is the exchange's most valuable company, to ...

AstraZeneca Plc’s shares rose after a report that Chief Executive Officer Pascal Soriot wants to move the British drugmaker’s ...

Just days after President Donald Trump was elected in November, AstraZeneca unvei | AstraZeneca CEO Pascal Soriot is plotting ...

The company's exit from the U.K. market would spark a major index re-weighting, given AstraZeneca is the most valuable ...

American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to directly list its sock on a ...

AstraZeneca chief executive Pascal Soriot is considering moving the company's stock exchange listing from the UK to the US – ...

AstraZeneca’s chief executive has discussed quitting Britain in a move that would deal a significant blow to the City of ...

The biopharmaceutical giant AstraZeneca is considering moving their stock listing from the London Stock Exchange to the US in ...

--AstraZeneca's chief executive is considering moving its listing from London to the U.S. due to U.K. restrictions on medicines and pricing, The Times reports, citing unnamed sources. --Pascal ...

Spain is investigating Novo Nordisk over concerns it may be illegally advertising its weight loss drugs Ozempic and Wegovy ...

(Reuters) -AstraZeneca CEO Pascal Soriot is considering moving the company's stock market listing to the U.S., the Times ...

CEO Pascal Soriot has privately expressed a preference to shift AstraZeneca's listing on multiple occasions and has also discussed relocating the company's domicile, the Times said. AstraZeneca ...